scholarly article | Q13442814 |
P2093 | author name string | Domenico Coppola | |
Srikumar P Chellappan | |||
Smitha Pillai | |||
Deepak Perumal | |||
Courtney Schaal | |||
Jonathan Nguyen | |||
P2860 | cites work | Nicotine promotes tumor growth and metastasis in mouse models of lung cancer | Q21142724 |
Global cancer statistics | Q22241238 | ||
Mammalian nicotinic acetylcholine receptors: from structure to function | Q24647069 | ||
Stem cells, cancer, and cancer stem cells | Q27860878 | ||
Stem cell factor and its receptor c-Kit as targets for inflammatory diseases | Q28115994 | ||
Tobacco smoke carcinogens and lung cancer | Q28140233 | ||
Overexpression of c-Maf contributes to T-cell lymphoma in both mice and human | Q28292703 | ||
Hematopoietic cytokines as tumor markers | Q28296229 | ||
The stem cell factor receptor/c-Kit as a drug target in cancer | Q28297193 | ||
A novel five gene signature derived from stem-like side population cells predicts overall and recurrence-free survival in NSCLC | Q28387995 | ||
Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo | Q29619355 | ||
Central nicotinic receptors: structure, function, ligands, and therapeutic potential. | Q33273397 | ||
Precancerous stem cells have the potential for both benign and malignant differentiation | Q33278288 | ||
DNA adduct formation from tobacco-specific N-nitrosamines | Q33538109 | ||
PTEN is a potent suppressor of small cell lung cancer. | Q33610833 | ||
Smoking and lung cancer survival: the role of comorbidity and treatment. | Q33975094 | ||
The nicotinic acetylcholine receptor CHRNA5/A3/B4 gene cluster: dual role in nicotine addiction and lung cancer | Q34126960 | ||
The SSX family of cancer-testis antigens as target proteins for tumor therapy | Q34146229 | ||
Expanding roles for beta-arrestins as scaffolds and adapters in GPCR signaling and trafficking. | Q34180619 | ||
EGFR/Src/Akt signaling modulates Sox2 expression and self-renewal of stem-like side-population cells in non-small cell lung cancer | Q34421001 | ||
Cigarette smoking: cancer risks, carcinogens, and mechanisms | Q34572870 | ||
ARRB1-mediated regulation of E2F target genes in nicotine-induced growth of lung tumors | Q34577233 | ||
βArrestin-1 and Mcl-1 modulate self-renewal growth of cancer stem-like side-population cells in non-small cell lung cancer | Q34589698 | ||
Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study | Q34798314 | ||
Nicotine induces cell proliferation by beta-arrestin-mediated activation of Src and Rb-Raf-1 pathways | Q34803242 | ||
Nicotine induces cell proliferation, invasion and epithelial-mesenchymal transition in a variety of human cancer cell lines | Q34849133 | ||
Continued cigarette smoking by patients receiving concurrent chemoradiotherapy for limited-stage small-cell lung cancer is associated with decreased survival | Q35107968 | ||
Nuclear localization of γ-tubulin affects E2F transcriptional activity and S-phase progression | Q35497058 | ||
Elimination of human lung cancer stem cells through targeting of the stem cell factor-c-kit autocrine signaling loop | Q36067817 | ||
Pharmacological blockade of a β(2)AR-β-arrestin-1 signaling cascade prevents the accumulation of DNA damage in a behavioral stress model | Q36618617 | ||
Nicotine-mediated cell proliferation and angiogenesis: new twists to an old story | Q36653002 | ||
Improved survival outcomes with the incidental use of beta-blockers among patients with non-small-cell lung cancer treated with definitive radiation therapy | Q36776988 | ||
Translational research in medication development for nicotine dependence | Q36906670 | ||
Nicotinic interactions with antipsychotic drugs, models of schizophrenia and impacts on cognitive function | Q36917265 | ||
From G0 to S phase: a view of the roles played by the retinoblastoma (Rb) family members in the Rb-E2F pathway | Q36989718 | ||
Is cancer triggered by altered signalling of nicotinic acetylcholine receptors? | Q37385793 | ||
Nicotinic acetylcholine receptor-mediated mechanisms in lung cancer | Q37884798 | ||
Expression and immunotherapeutic targeting of the SSX family of cancer-testis antigens in prostate cancer | Q39481670 | ||
Nicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induce cyclooxygenase-2 activity in human gastric cancer cells: Involvement of nicotinic acetylcholine receptor (nAChR) and beta-adrenergic receptor signaling pathways | Q39937686 | ||
Hypoxia-inducible factor (HIF)-1 alpha directly enhances the transcriptional activity of stem cell factor (SCF) in response to hypoxia and epidermal growth factor (EGF). | Q40002656 | ||
Cigarette smoke components inhibited intercellular communication and differentiation in human pancreatic ductal epithelial cells | Q40176971 | ||
The kit ligand, stem cell factor | Q40386264 | ||
A human- and male-specific protocadherin that acts through the wnt signaling pathway to induce neuroendocrine transdifferentiation of prostate cancer cells. | Q40408972 | ||
Stem cell factor as a survival and growth factor in human normal and malignant hematopoiesis | Q41013464 | ||
Recombinant human stem cell factor mediates chemotaxis of small-cell lung cancer cell lines aberrantly expressing the c-kit protooncogene | Q41564993 | ||
Requirement for mast cell growth factor for primordial germ cell survival in culture | Q41668856 | ||
Prediction of recurrence-free survival in postoperative non-small cell lung cancer patients by using an integrated model of clinical information and gene expression | Q44571511 | ||
Stem cell factor is a chemoattractant and a survival factor for CNS stem cells | Q45142298 | ||
c-Kit expression in human normal and malignant stem cells prognostic and therapeutic implications | Q46474874 | ||
The Expression of c-kit Protein during Oogenesis and Early Embryonic Development1 | Q50797507 | ||
PTEN mutations and relationship to EGFR, ERBB2, KRAS, and TP53 mutations in non-small cell lung cancers. | Q53486364 | ||
Lung cancer | Q73858423 | ||
The effect of smoking status on survival following radiation therapy for non-small cell lung cancer | Q80081395 | ||
New directions in reducing stress effects on cancer | Q83394024 | ||
P433 | issue | 21 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 10486-10502 | |
P577 | publication date | 2014-11-01 | |
P1433 | published in | Oncotarget | Q1573155 |
P1476 | title | Nicotinic acetylcholine receptors induce c-Kit ligand/Stem Cell Factor and promote stemness in an ARRB1/ β-arrestin-1 dependent manner in NSCLC. | |
P478 | volume | 5 |
Q64068836 | Distinct Prognostic Values of Phospholipase C Beta Family Members for Non-Small Cell Lung Carcinoma |
Q58698632 | Distinct prognostic values of mRNA expression of glutathione peroxidases in non-small cell lung cancer |
Q37207489 | Evaluation of the relationship between c-Kit expression and mean platelet volume in classic Kaposi's sarcoma |
Q47129993 | Genome-wide DNA methylation profiling reveals novel epigenetic signatures in squamous cell lung cancer |
Q90706187 | Identification of biomarkers associated with histological grade and prognosis of gastric cancer by co-expression network analysis |
Q55241601 | In cancer cell lines inhibition of SCF/c-Kit pathway leads to radiosensitization only when SCF is strongly over-expressed. |
Q36543364 | Interrupted E2F1-miR-34c-SCF negative feedback loop by hyper-methylation promotes colorectal cancer cell proliferation |
Q40621763 | Loss of β-arrestin1 expression predicts unfavorable prognosis for non-small cell lung cancer patients |
Q64229777 | New Routes in GPCR/β-Arrestin-Driven Signaling in Cancer Progression and Metastasis |
Q37109600 | Nuclear β-arrestin1 is a critical cofactor of hypoxia-inducible factor-1α signaling in endothelin-1-induced ovarian tumor progression. |
Q52614372 | Prognostic Roles of mRNA Expression of S100 in Non-Small-Cell Lung Cancer. |
Q39035573 | Prognostic roles of mRNA expression of notch receptors in non-small cell lung cancer |
Q57464559 | Regulation of Sox2 and stemness by nicotine and electronic-cigarettes in non-small cell lung cancer |
Q48010163 | Targeting endothelin-1 receptor/β-arrestin1 network for the treatment of ovarian cancer |
Q91761018 | β-Arrestins Regulate Stem Cell-Like Phenotype and Response to Chemotherapy in Bladder Cancer |
Q26740489 | β-arrestin1 at the cross-road of endothelin-1 signaling in cancer |
Q92034546 | β-arrestin1/YAP/mutant p53 complexes orchestrate the endothelin A receptor signaling in high-grade serous ovarian cancer |
Search more.